Brief: Medicenna Announces Nasdaq Delisting And Cutback Of Management Team

Medicenna Therapeutics

27/10/2023 13:12

Oct 27 (Reuters) - Medicenna Therapeutics Corp
 MDNA.TO :
    * MEDICENNA ANNOUNCES NASDAQ DELISTING AND CUTBACK OF
MANAGEMENT
TEAM
    * MEDICENNA THERAPEUTICS CORP - DEPARTURE OF JEFF CARAVELLA
AS
CHIEF FINANCIAL OFFICER
    * MEDICENNA THERAPEUTICS CORP - DEPARTURE OF BRENT MEADOWS
AS
CHIEF BUSINESS OFFICER, EFFECTIVE OCTOBER 26 IN CONNECTION WITH
NASDAQ DELISTING
    * MEDICENNA THERAPEUTICS - HAVE SUFFICIENT CASH TO FUND CO
BEYOND
KEY VALUE INFLECTION MILESTONES FROM MDNA11 PHASE 2 MONOTHERAPY
AND COMBINATION TRIAL

Source text for Eikon:  ID:nGNX9jQLGK 
Further company coverage:  MDNA.TO 

 ((Reuters.Briefs@thomsonreuters.com;))